GMP Inspection Results Can No Longer Stay Within Borders, Says FDA
This article was originally published in The Gray Sheet
Executive Summary
Results from manufacturing facility inspections conducted in one country will easily be shared with regulators in another in the near term, says Larry Kessler, FDA officer and chair of the Global Harmonization Task Force
You may also be interested in...
FDA Will Inspect Firms That Didn’t Participate In U.S.-Canada Program
Manufacturers that turned down FDA's offer to participate in its Pilot Multipurpose Audit Program (PMAP) will soon be inspected by the agency, CDRH's compliance chief says
FDA Will Inspect Firms That Didn’t Participate In U.S.-Canada Program
Manufacturers that turned down FDA's offer to participate in its Pilot Multipurpose Audit Program (PMAP) will soon be inspected by the agency, CDRH's compliance chief says
Industry Reluctant To Join Regulatory Harmonization Pilots
Global harmonization of manufacturing quality inspections could move forward if firms would agree to try new approaches, FDA maintains, but industry worries that taking that leap could bring risks